Frequency Therapeutics

53 employees

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Genetics

Medical

Date founded

2015

Funding rounds raised

Total raised

$42M

from 20 investors over 20 rounds

Frequency Therapeutics raised undisclosed on August 15, 2022

Investors: Taiwania Capital

Frequency Therapeutics raised $42M on July 17, 2020

Investors: RTW Investments, LP, WASATCH ADVISORS, INC, Driehaus Capital Management LLC and Perceptive Advisors

Frequency Therapeutics raised undisclosed on July 23, 2019

Investors: RTW Investments, LP, Perceptive Advisors, COBRO VENTURES, INC, みずほ証券プリンシパルインベストメント（株）, Axil Capital Partners, Axil Capital Advisors K.K., Taiwania Capital and Polaris Founders Capital

Frequency Therapeutics raised undisclosed on January 7, 2019

Investors: COBRO VENTURES, INC, Korea Investment Partners, Emigrant Capital Corporation and Taiwania Capital

Frequency Therapeutics raised $2M on May 30, 2018

Investors: united-states-department-of-defense

Frequency Therapeutics raised $32M on April 11, 2017

Investors: Emigrant Capital Corporation, Korea Investment Partners and COBRO VENTURES, INC